Pub Date : 2026-03-09eCollection Date: 2026-01-01DOI: 10.1155/prm/8752885
S Eldafrawi, T Elsewify, B Eid
Background: Pain control remains a cornerstone in endodontic practice, particularly in cases of symptomatic irreversible pulpitis where achieving profound anaesthesia is often challenging. As the inferior alveolar nerve block (IANB) frequently fails to provide profound pulpal anaesthesia, optimizing pain control in such cases requires evidence-based modifications to anaesthetic techniques and the use of supplemental approaches.
Aim: This narrative review aims to synthesize current evidence on clinical strategies for improving pain management in mandibular molars with symptomatic irreversible pulpitis, with particular emphasis on enhancing the efficacy of IANB and supplemental injection techniques.
Methods: A narrative review methodology was employed to synthesize clinical trials and systematic reviews published between 1975 and 2025.
Results: Evidence indicates that increasing the anaesthetic volume and applying supplemental techniques, including intraligamentary, intraosseous and intrapulpal injections, significantly enhances anaesthesia success. Adjunctive measures such as cryotherapy and temperature modification of anaesthetic solutions further improve pain control. The integration of these methods provides a predictable and multimodal approach to managing endodontic pain in challenging clinical scenarios.
Conclusion: Effective pain management in mandibular molars with symptomatic irreversible pulpitis relies on a comprehensive strategy that combines optimized anaesthetic volume and supplemental techniques. Intrapulpal anaesthesia remains essential for achieving pulpal anaesthesia when all other techniques fail. Continued clinical research is essential to refine these approaches and establish standardized protocols for achieving reliable anaesthesia in endodontic practice.
{"title":"Pain Management in Mandibular Molars With Symptomatic Irreversible Pulpitis: Mechanisms, Clinical Efficacy and Current Evidence: A Narrative Review.","authors":"S Eldafrawi, T Elsewify, B Eid","doi":"10.1155/prm/8752885","DOIUrl":"https://doi.org/10.1155/prm/8752885","url":null,"abstract":"<p><strong>Background: </strong>Pain control remains a cornerstone in endodontic practice, particularly in cases of symptomatic irreversible pulpitis where achieving profound anaesthesia is often challenging. As the inferior alveolar nerve block (IANB) frequently fails to provide profound pulpal anaesthesia, optimizing pain control in such cases requires evidence-based modifications to anaesthetic techniques and the use of supplemental approaches.</p><p><strong>Aim: </strong>This narrative review aims to synthesize current evidence on clinical strategies for improving pain management in mandibular molars with symptomatic irreversible pulpitis, with particular emphasis on enhancing the efficacy of IANB and supplemental injection techniques.</p><p><strong>Methods: </strong>A narrative review methodology was employed to synthesize clinical trials and systematic reviews published between 1975 and 2025.</p><p><strong>Results: </strong>Evidence indicates that increasing the anaesthetic volume and applying supplemental techniques, including intraligamentary, intraosseous and intrapulpal injections, significantly enhances anaesthesia success. Adjunctive measures such as cryotherapy and temperature modification of anaesthetic solutions further improve pain control. The integration of these methods provides a predictable and multimodal approach to managing endodontic pain in challenging clinical scenarios.</p><p><strong>Conclusion: </strong>Effective pain management in mandibular molars with symptomatic irreversible pulpitis relies on a comprehensive strategy that combines optimized anaesthetic volume and supplemental techniques. Intrapulpal anaesthesia remains essential for achieving pulpal anaesthesia when all other techniques fail. Continued clinical research is essential to refine these approaches and establish standardized protocols for achieving reliable anaesthesia in endodontic practice.</p>","PeriodicalId":19913,"journal":{"name":"Pain Research & Management","volume":"2026 ","pages":"8752885"},"PeriodicalIF":3.0,"publicationDate":"2026-03-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12968732/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147434701","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-08eCollection Date: 2026-01-01DOI: 10.1155/prm/6462957
Liangqing Gao, Ruifang Zhang, Yizhi Xiao, Chengmin Ma, Xiaofeng Li
Background: Although pain management plays an important role in the treatment of acute pancreatitis (AP), current guidelines lack clear and consistent recommendations for the management of abdominal pain. The aim of this study was to investigate factors associated with analgesic use in Chinese hospitalized patients with AP.
Methods: This was a single-center retrospective study. Patients discharged with a diagnosis of AP were consecutively included. Patients were divided into the analgesic group and the nonanalgesic group based on whether they received analgesic therapy. Clinical parameters, including baseline pain scores and serum lipase level, were compared using univariate analysis and multivariate logistic regression.
Results: A total of 151 patients were included, with 69 (45.7%) receiving analgesic treatment and 82 (54.3%) receiving no analgesics. Patients with moderate-to-severe pain (score 4-7) at admission were 6.86 times more likely to receive analgesics than pain-free patients (95% confidence interval [CI]:1.12-41.99, p = 0.037). Moderately severe and severe AP (vs. mild) were associated with 2.94-fold (odds ratio [OR] = 3.94, 95% CI: 1.19-12.98, p = 0.024) and 4.05-fold (OR = 5.05, 95% CI: 1.22-20.8, p = 0.025) increased risk of analgesic use, respectively. Although 108.1 U/L ≤ lipase level < 293.4 U/L and 293.4 U/L ≤ lipase level < 809.6 U/L (vs.< 108.1 U/L) did not significantly increase analgesic use risk, patients with lipase level ≥ 809.6 U/L had a 2.8-fold increased risk (OR = 3.8, 95% CI: 1.27-11.37, p = 0.017).
Conclusions: Elevated serum lipase (≥ 809.6 U/L), higher baseline pain scores, and AP severity are key factors associated with analgesic use in Chinese AP patients. These findings highlight serum lipase as a potential biomarker for individualized pain management strategies in AP.
背景:尽管疼痛管理在急性胰腺炎(AP)的治疗中起着重要作用,但目前的指南缺乏明确和一致的腹痛管理建议。本研究的目的是探讨中国住院ap患者使用镇痛药的相关因素。方法:采用单中心回顾性研究。连续纳入诊断为AP的出院患者。根据患者是否接受镇痛治疗分为镇痛组和非镇痛组。临床参数,包括基线疼痛评分和血清脂肪酶水平,采用单因素分析和多因素logistic回归进行比较。结果:共纳入151例患者,其中69例(45.7%)接受了镇痛治疗,82例(54.3%)未接受镇痛治疗。入院时出现中重度疼痛(评分4-7分)的患者使用镇痛药的可能性是无疼痛患者的6.86倍(95%可信区间[CI]:1.12-41.99, p = 0.037)。中度和重度AP(与轻度AP相比)分别与2.94倍(优势比[OR] = 3.94, 95% CI: 1.19-12.98, p = 0.024)和4.05倍(OR = 5.05, 95% CI: 1.22-20.8, p = 0.025)使用镇痛药的风险增加相关。虽然108.1 U/L≤脂肪酶水平p = 0.017)。结论:血清脂肪酶升高(≥809.6 U/L)、基线疼痛评分较高和AP严重程度是影响中国AP患者使用镇痛药的关键因素。这些发现强调了血清脂肪酶作为AP个体化疼痛管理策略的潜在生物标志物。
{"title":"High Serum Lipase Level is Associated With Increased Analgesic Use in Hospitalized Patients With Acute Pancreatitis.","authors":"Liangqing Gao, Ruifang Zhang, Yizhi Xiao, Chengmin Ma, Xiaofeng Li","doi":"10.1155/prm/6462957","DOIUrl":"https://doi.org/10.1155/prm/6462957","url":null,"abstract":"<p><strong>Background: </strong>Although pain management plays an important role in the treatment of acute pancreatitis (AP), current guidelines lack clear and consistent recommendations for the management of abdominal pain. The aim of this study was to investigate factors associated with analgesic use in Chinese hospitalized patients with AP.</p><p><strong>Methods: </strong>This was a single-center retrospective study. Patients discharged with a diagnosis of AP were consecutively included. Patients were divided into the analgesic group and the nonanalgesic group based on whether they received analgesic therapy. Clinical parameters, including baseline pain scores and serum lipase level, were compared using univariate analysis and multivariate logistic regression.</p><p><strong>Results: </strong>A total of 151 patients were included, with 69 (45.7%) receiving analgesic treatment and 82 (54.3%) receiving no analgesics. Patients with moderate-to-severe pain (score 4-7) at admission were 6.86 times more likely to receive analgesics than pain-free patients (95% confidence interval [CI]:1.12-41.99, <i>p</i> = 0.037). Moderately severe and severe AP (vs. mild) were associated with 2.94-fold (odds ratio [OR] = 3.94, 95% CI: 1.19-12.98, <i>p</i> = 0.024) and 4.05-fold (OR = 5.05, 95% CI: 1.22-20.8, <i>p</i> = 0.025) increased risk of analgesic use, respectively. Although 108.1 U/L ≤ lipase level < 293.4 U/L and 293.4 U/L ≤ lipase level < 809.6 U/L (vs.< 108.1 U/L) did not significantly increase analgesic use risk, patients with lipase level ≥ 809.6 U/L had a 2.8-fold increased risk (OR = 3.8, 95% CI: 1.27-11.37, <i>p</i> = 0.017).</p><p><strong>Conclusions: </strong>Elevated serum lipase (≥ 809.6 U/L), higher baseline pain scores, and AP severity are key factors associated with analgesic use in Chinese AP patients. These findings highlight serum lipase as a potential biomarker for individualized pain management strategies in AP.</p>","PeriodicalId":19913,"journal":{"name":"Pain Research & Management","volume":"2026 ","pages":"6462957"},"PeriodicalIF":3.0,"publicationDate":"2026-03-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12968432/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147434688","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-03eCollection Date: 2026-01-01DOI: 10.1155/prm/5086518
Mengyun Zhang, Hao Wu, Han Zheng, Jing Zhang, Jiaxuan Wang, Hong Luo, Heng Yang
<p><strong>Context: </strong>Laparoscopic cholecystectomy (LC) often leads to abdominal wall incision pain, visceral pain, and shoulder and neck pain after surgery. Nalbuphine provides strong sedative and analgesic effects with minimal risk of adverse reactions. Esketamine, with its higher receptor affinity, significantly alleviates both visceral and somatic pain.</p><p><strong>Objectives: </strong>Our objective was to establish the optimal dosage of nalbuphine with esketamine for patient-controlled intravenous analgesia (PCIA) following LC, enhancing postoperative pain management for these patients.</p><p><strong>Methods: </strong>This research employs a single-blind, randomized controlled trial methodology. Surgical patients were randomly assigned to three groups based on postoperative PCIA drug combinations: Group N received nalbuphine 2 mg·kg<sup>-1</sup> with 100 mL of 0.9% sodium chloride solution; Group NE<sub>1</sub> received esketamine 0.5 mg·kg<sup>-1</sup>, nalbuphine 2 mg·kg<sup>-1</sup>, and 100 mL of 0.9% sodium chloride solution; Group NE<sub>2</sub> received esketamine 1 mg·kg<sup>-1</sup>, nalbuphine 2 mg·kg<sup>-1</sup>, and 100 mL of 0.9% sodium chloride solution. The study observed VAS scores at rest and during activity, Ramsay sedation scores, and MoCA scores at 6, 12, 24, and 48 h postsurgery, along with the total and effective PCIA pressing times across the three groups. Adverse reactions and the frequency of rescue analgesia within 48 h postsurgery were monitored.</p><p><strong>Results: </strong>Compared to the N group, VAS scores and resting pain scores were substantially lower in the NE<sub>1</sub> and NE<sub>2</sub> groups at 6 h, 12 h, and 24 h postsurgery (<i>p</i> < 0.05). Compared to Group N, Groups NE<sub>1</sub> and NE<sub>2</sub> had reduced postactivity VAS scores at 48 h postsurgery (<i>p</i> < 0.05). Compared to Group NE<sub>1</sub>, Group NE<sub>2</sub> had reduced VAS scores at 12 h and 24 h following surgery (<i>p</i> < 0.05). Compared with Group N, the Ramsay sedation scores were higher in Group NE<sub>1</sub> and Group NE<sub>2</sub> at 6 h, 12 h, and 24 h following surgery (<i>p</i> < 0.05). Compared with Group NE<sub>1</sub>, Group NE<sub>2</sub> had higher Ramsay sedation scores at 6 h and 12 h postoperatively (<i>p</i> < 0.05). The total number of analgesic pump presses and the number of effective presses in the NE<sub>1</sub> and NE<sub>2</sub> groups were substantially lower than those in the N group (<i>p</i> < 0.05). Compared with the NE<sub>1</sub> group, the total number of presses and the number of effective presses in the NE<sub>2</sub> group were reduced at 24 h and 48 h postoperatively (<i>p</i> < 0.05). Compared with Group N, the cognitive scores on the MoCA scale were markedly increased in Group NE<sub>1</sub> and Group NE<sub>2</sub> at 6 h, 12 h, and 24 h postoperatively (<i>p</i> < 0.05). The incidence of vomiting was substantially lower in the NE<sub>1</sub> and NE<sub>2</sub> groups
{"title":"Appropriate Combination of Nalbuphine Combined With Esketamine for Weakly Opioid Anesthesia in Postlaparoscopic Cholecystectomy Analgesia: A Randomized Controlled Trial.","authors":"Mengyun Zhang, Hao Wu, Han Zheng, Jing Zhang, Jiaxuan Wang, Hong Luo, Heng Yang","doi":"10.1155/prm/5086518","DOIUrl":"10.1155/prm/5086518","url":null,"abstract":"<p><strong>Context: </strong>Laparoscopic cholecystectomy (LC) often leads to abdominal wall incision pain, visceral pain, and shoulder and neck pain after surgery. Nalbuphine provides strong sedative and analgesic effects with minimal risk of adverse reactions. Esketamine, with its higher receptor affinity, significantly alleviates both visceral and somatic pain.</p><p><strong>Objectives: </strong>Our objective was to establish the optimal dosage of nalbuphine with esketamine for patient-controlled intravenous analgesia (PCIA) following LC, enhancing postoperative pain management for these patients.</p><p><strong>Methods: </strong>This research employs a single-blind, randomized controlled trial methodology. Surgical patients were randomly assigned to three groups based on postoperative PCIA drug combinations: Group N received nalbuphine 2 mg·kg<sup>-1</sup> with 100 mL of 0.9% sodium chloride solution; Group NE<sub>1</sub> received esketamine 0.5 mg·kg<sup>-1</sup>, nalbuphine 2 mg·kg<sup>-1</sup>, and 100 mL of 0.9% sodium chloride solution; Group NE<sub>2</sub> received esketamine 1 mg·kg<sup>-1</sup>, nalbuphine 2 mg·kg<sup>-1</sup>, and 100 mL of 0.9% sodium chloride solution. The study observed VAS scores at rest and during activity, Ramsay sedation scores, and MoCA scores at 6, 12, 24, and 48 h postsurgery, along with the total and effective PCIA pressing times across the three groups. Adverse reactions and the frequency of rescue analgesia within 48 h postsurgery were monitored.</p><p><strong>Results: </strong>Compared to the N group, VAS scores and resting pain scores were substantially lower in the NE<sub>1</sub> and NE<sub>2</sub> groups at 6 h, 12 h, and 24 h postsurgery (<i>p</i> < 0.05). Compared to Group N, Groups NE<sub>1</sub> and NE<sub>2</sub> had reduced postactivity VAS scores at 48 h postsurgery (<i>p</i> < 0.05). Compared to Group NE<sub>1</sub>, Group NE<sub>2</sub> had reduced VAS scores at 12 h and 24 h following surgery (<i>p</i> < 0.05). Compared with Group N, the Ramsay sedation scores were higher in Group NE<sub>1</sub> and Group NE<sub>2</sub> at 6 h, 12 h, and 24 h following surgery (<i>p</i> < 0.05). Compared with Group NE<sub>1</sub>, Group NE<sub>2</sub> had higher Ramsay sedation scores at 6 h and 12 h postoperatively (<i>p</i> < 0.05). The total number of analgesic pump presses and the number of effective presses in the NE<sub>1</sub> and NE<sub>2</sub> groups were substantially lower than those in the N group (<i>p</i> < 0.05). Compared with the NE<sub>1</sub> group, the total number of presses and the number of effective presses in the NE<sub>2</sub> group were reduced at 24 h and 48 h postoperatively (<i>p</i> < 0.05). Compared with Group N, the cognitive scores on the MoCA scale were markedly increased in Group NE<sub>1</sub> and Group NE<sub>2</sub> at 6 h, 12 h, and 24 h postoperatively (<i>p</i> < 0.05). The incidence of vomiting was substantially lower in the NE<sub>1</sub> and NE<sub>2</sub> groups ","PeriodicalId":19913,"journal":{"name":"Pain Research & Management","volume":"2026 ","pages":"5086518"},"PeriodicalIF":3.0,"publicationDate":"2026-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12957776/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147365993","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-01eCollection Date: 2026-01-01DOI: 10.1155/prm/3112089
Omid Khoshavi, Shannon L Merkle, Charles J Paul, Laura A Frey-Law
Background: Research highlights the potential role of physical activity (PA) in preventing chronic pain and reducing both acute and persistent pain symptoms. While increasing PA is an evidence-based intervention for chronic pain, the relationship between pain processing and PA remains unclear. This study aimed to investigate associations of both PA and fitness assessments with multiple measures of pain sensitivity, hypothesizing links with both static and dynamic pain sensitivity metrics.
Methods: Sixty-four healthy adults (30 female) representing both high and low activity levels completed a series of pressure-based quantitative sensory tests (QST), including static measures (pressure pain thresholds [PPTs]) and dynamic measures (temporal summation [TS] and conditioned pain modulation [CPM]). PA was evaluated using the International Physical Activity Questionnaire (IPAQ, self-report) and accelerometry (objective). Cardiorespiratory fitness (CRF) was assessed using the YMCA step test. Correlation and regression analyses were used to evaluate these relationships.
Results: Higher PPTs were related to more self-reported moderate-to-vigorous PA, vigorous PA, and total PA; accelerometry vigorous PA; and high CRF (p ≤ 0.01). Self-reported vigorous PA was inversely correlated with TS (p = 0.01), while the other PA or CRF metrics were not significantly associated with either TS or CPM (p ≥ 0.04).
Conclusion: CRF or vigorous PA metrics were more consistently related to static pressure QST (PPT) than to dynamic QST (TS and CPM). Our findings in a single cohort mirror the inconsistencies noted across cohorts in the literature, suggesting that PA and CRF exhibit distinct relationships with various QST measures.
{"title":"High Cardiorespiratory Fitness and Vigorous Physical Activity Relate to Select Pain Sensitivity Assessments in Healthy Adults: A Cross-Sectional Study.","authors":"Omid Khoshavi, Shannon L Merkle, Charles J Paul, Laura A Frey-Law","doi":"10.1155/prm/3112089","DOIUrl":"10.1155/prm/3112089","url":null,"abstract":"<p><strong>Background: </strong>Research highlights the potential role of physical activity (PA) in preventing chronic pain and reducing both acute and persistent pain symptoms. While increasing PA is an evidence-based intervention for chronic pain, the relationship between pain processing and PA remains unclear. This study aimed to investigate associations of both PA and fitness assessments with multiple measures of pain sensitivity, hypothesizing links with both static and dynamic pain sensitivity metrics.</p><p><strong>Methods: </strong>Sixty-four healthy adults (30 female) representing both high and low activity levels completed a series of pressure-based quantitative sensory tests (QST), including static measures (pressure pain thresholds [PPTs]) and dynamic measures (temporal summation [TS] and conditioned pain modulation [CPM]). PA was evaluated using the International Physical Activity Questionnaire (IPAQ, self-report) and accelerometry (objective). Cardiorespiratory fitness (CRF) was assessed using the YMCA step test. Correlation and regression analyses were used to evaluate these relationships.</p><p><strong>Results: </strong>Higher PPTs were related to more self-reported moderate-to-vigorous PA, vigorous PA, and total PA; accelerometry vigorous PA; and high CRF (<i>p</i> ≤ 0.01). Self-reported vigorous PA was inversely correlated with TS (<i>p</i> = 0.01), while the other PA or CRF metrics were not significantly associated with either TS or CPM (<i>p</i> ≥ 0.04).</p><p><strong>Conclusion: </strong>CRF or vigorous PA metrics were more consistently related to static pressure QST (PPT) than to dynamic QST (TS and CPM). Our findings in a single cohort mirror the inconsistencies noted across cohorts in the literature, suggesting that PA and CRF exhibit distinct relationships with various QST measures.</p>","PeriodicalId":19913,"journal":{"name":"Pain Research & Management","volume":"2026 ","pages":"3112089"},"PeriodicalIF":3.0,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12950830/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147348862","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-27eCollection Date: 2026-01-01DOI: 10.1155/prm/6643204
Frank Fan Huang, Ming-Wang Qiu, Wan-Ming Wu, Jia-Jun Liu, Qingkai Zhao, Si-Yi Zhao, Man-Qi Lu, Zhao-Xian Yan, Jia-Qi Li, Xian Liu, Yi-Kai Li, Arnold Yu Lok Wong, Zhi-Yong Fan
Background: Prior research has demonstrated the clinical efficacy of two specialized Tuina techniques, namely, high-speed oblique Tuina (HSOT) and low-speed oblique Tuina (LSOT), in the treatment of lumbar disc herniation (LDH). These techniques integrate principles of traditional Chinese medicine with modern manual therapy. Despite their proven therapeutic benefits, the biomechanical effects of HSOT and LSOT on spinal structures remain poorly understood.
Aim: Finite element analysis (FEA) was utilized to investigate the biomechanical effects of HSOT and LSOT on a patient with LDH, aiming to elucidate their underlying treatment mechanisms.
Methods: The mechanical parameters of HSOT and LSOT applied to a participant with left L4/5 LDH were meticulously measured using a state-of-the-art Multipoint Thin Film Pressure Testing System. These comprehensive data, along with the corresponding high-resolution computerized tomography (CT) scan data, were subsequently input into four advanced finite element analysis (FEA) software programs. These programs were employed to conduct a detailed analysis of the stress-strain characteristics of both HSOT and LSOT on the spinal structures, enabling a thorough comparison of their biomechanical effects and potential therapeutic outcomes.
Results: The maximum stress and average displacement of vertebral and ligamentous structures during HSOT in the lumbar vertebrae-pelvis model doubled those of LSOT. HSOT caused the maximum average displacement of the L4/5 right intertransverse ligament, whereas LSOT induced the maximal mean displacement of the L4/5 left intertransverse ligament. Additionally, HSOT caused the maximum average displacement of the right iliolumbar ligament, but the maximum mean displacement was observed in the left iliolumbar ligament during LSOT.
Conclusion: Both HSOT and LSOT produced small displacements of the lumbar and pelvic structures, but HSOT elicited significantly greater displacement and stress on various spinal tissues than LSOT. These mechanical responses may be the biomechanical effects of HSOT and LSOT in people with LDH. Trial Registration: ClinicalTrials.gov identifier: ChiCTR2200065450.
{"title":"Biomechanical Comparisons of Two Types of Tuina in Treating Lumbar Disc Herniation: A Finite Element Analysis.","authors":"Frank Fan Huang, Ming-Wang Qiu, Wan-Ming Wu, Jia-Jun Liu, Qingkai Zhao, Si-Yi Zhao, Man-Qi Lu, Zhao-Xian Yan, Jia-Qi Li, Xian Liu, Yi-Kai Li, Arnold Yu Lok Wong, Zhi-Yong Fan","doi":"10.1155/prm/6643204","DOIUrl":"10.1155/prm/6643204","url":null,"abstract":"<p><strong>Background: </strong>Prior research has demonstrated the clinical efficacy of two specialized Tuina techniques, namely, high-speed oblique Tuina (HSOT) and low-speed oblique Tuina (LSOT), in the treatment of lumbar disc herniation (LDH). These techniques integrate principles of traditional Chinese medicine with modern manual therapy. Despite their proven therapeutic benefits, the biomechanical effects of HSOT and LSOT on spinal structures remain poorly understood.</p><p><strong>Aim: </strong>Finite element analysis (FEA) was utilized to investigate the biomechanical effects of HSOT and LSOT on a patient with LDH, aiming to elucidate their underlying treatment mechanisms.</p><p><strong>Methods: </strong>The mechanical parameters of HSOT and LSOT applied to a participant with left L4/5 LDH were meticulously measured using a state-of-the-art Multipoint Thin Film Pressure Testing System. These comprehensive data, along with the corresponding high-resolution computerized tomography (CT) scan data, were subsequently input into four advanced finite element analysis (FEA) software programs. These programs were employed to conduct a detailed analysis of the stress-strain characteristics of both HSOT and LSOT on the spinal structures, enabling a thorough comparison of their biomechanical effects and potential therapeutic outcomes.</p><p><strong>Results: </strong>The maximum stress and average displacement of vertebral and ligamentous structures during HSOT in the lumbar vertebrae-pelvis model doubled those of LSOT. HSOT caused the maximum average displacement of the L4/5 right intertransverse ligament, whereas LSOT induced the maximal mean displacement of the L4/5 left intertransverse ligament. Additionally, HSOT caused the maximum average displacement of the right iliolumbar ligament, but the maximum mean displacement was observed in the left iliolumbar ligament during LSOT.</p><p><strong>Conclusion: </strong>Both HSOT and LSOT produced small displacements of the lumbar and pelvic structures, but HSOT elicited significantly greater displacement and stress on various spinal tissues than LSOT. These mechanical responses may be the biomechanical effects of HSOT and LSOT in people with LDH. <b>Trial Registration:</b> ClinicalTrials.gov identifier: ChiCTR2200065450.</p>","PeriodicalId":19913,"journal":{"name":"Pain Research & Management","volume":"2026 ","pages":"6643204"},"PeriodicalIF":3.0,"publicationDate":"2026-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12949095/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147326884","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Ganglion impar block (GIB) is a commonly used interventional option for refractory chronic coccydynia. Caudal epidural steroid injection (CESI) targets the sacral and coccygeal roots and may theoretically augment the analgesic efficacy of GIB. Evidence comparing GIB alone with a combined GIB and CESI approach, however, remains limited. This study compared long-term pain outcomes after GIB monotherapy versus GIB combined with CESI.
Methods: In this retrospective single-center study (Jan 2020-May 2025), we evaluated 56 adults with chronic coccydynia who underwent GIB alone (Group A) or in combination with CESI (Group B). Pain intensity was assessed using the 11-point numeric rating scale (NRS-11) at baseline and at 1 h, 1 month, and 6 months after the procedure. Multivariable logistic regression was used to explore predictors of 6-month response, including early postprocedural pain change and sex.
Results: Significant improvements in pain intensity were observed in both groups and sustained over 6 months. Responder rates at 6 months were comparable between the GIB-only (41.7%) and GIB with CESI (45.0%) groups (p > 0.05). Multivariable analysis revealed that greater early pain relief (baseline to 1 h) significantly predicted 6-month favorable outcomes (OR: 2.08; 95% CI: 1.26-3.42; p = 0.004), whereas male sex was associated with significantly reduced odds of response (OR: 0.11; 95% CI: 0.02-0.72; p = 0.022).
Conclusions: In this single-center retrospective cohort, GIB was associated with sustained pain relief in a substantial proportion of patients with chronic coccydynia, while the addition of CESI did not confer a clear incremental benefit. Importantly, immediate postprocedural pain relief served as a robust predictor of long-term success, whereas male sex was identified as a negative prognostic factor. Prospective, adequately powered randomized trials are needed to confirm these exploratory findings and to refine patient selection for GIB-based interventions. Trial Registration: ClinicalTrials.gov Identifier: NCT07200765.
背景:神经节阻滞(GIB)是治疗难治性慢性尾骨痛的常用介入治疗方法。尾侧硬膜外类固醇注射(CESI)针对骶骨和尾骨根,理论上可以增强GIB的镇痛效果。然而,比较单独GIB与联合GIB和CESI方法的证据仍然有限。这项研究比较了GIB单药治疗与GIB联合CESI治疗后的长期疼痛结果。方法:在这项回顾性单中心研究(2020年1月- 2025年5月)中,我们评估了56名单独接受GIB (A组)或联合CESI (B组)的慢性尾骨痛成人患者。在基线、术后1小时、1个月和6个月采用11点数值评定量表(NRS-11)评估疼痛强度。采用多变量逻辑回归探讨6个月反应的预测因素,包括术后早期疼痛变化和性别。结果:两组患者疼痛强度均有明显改善,且持续时间超过6个月。仅GIB组(41.7%)和GIB组(45.0%)6个月时的应答率具有可比性(p < 0.05)。多变量分析显示,较早的疼痛缓解(基线至1小时)显著预示6个月的有利结果(OR: 2.08; 95% CI: 1.26-3.42; p = 0.004),而男性与显著降低的反应几率相关(OR: 0.11; 95% CI: 0.02-0.72; p = 0.022)。结论:在这个单中心回顾性队列中,GIB与相当比例的慢性尾骨痛患者的持续疼痛缓解有关,而CESI的增加并没有带来明显的增量益处。重要的是,术后疼痛的立即缓解是长期成功的有力预测因素,而男性被认为是一个负面的预后因素。需要前瞻性、充分有力的随机试验来证实这些探索性发现,并完善基于gib干预措施的患者选择。试验注册:ClinicalTrials.gov标识符:NCT07200765。
{"title":"Predictors of Long-Term Response to Ganglion Impar Block With or Without Caudal Epidural Steroid Injection in Chronic Coccydynia: A Retrospective Study.","authors":"Kaan Yavuz, Mesut Bakir, Bedri Ilcan, Ezgi Bercem, Nureddin Teker, Sebnem Rumeli","doi":"10.1155/prm/8614330","DOIUrl":"10.1155/prm/8614330","url":null,"abstract":"<p><strong>Background: </strong>Ganglion impar block (GIB) is a commonly used interventional option for refractory chronic coccydynia. Caudal epidural steroid injection (CESI) targets the sacral and coccygeal roots and may theoretically augment the analgesic efficacy of GIB. Evidence comparing GIB alone with a combined GIB and CESI approach, however, remains limited. This study compared long-term pain outcomes after GIB monotherapy versus GIB combined with CESI.</p><p><strong>Methods: </strong>In this retrospective single-center study (Jan 2020-May 2025), we evaluated 56 adults with chronic coccydynia who underwent GIB alone (Group A) or in combination with CESI (Group B). Pain intensity was assessed using the 11-point numeric rating scale (NRS-11) at baseline and at 1 h, 1 month, and 6 months after the procedure. Multivariable logistic regression was used to explore predictors of 6-month response, including early postprocedural pain change and sex.</p><p><strong>Results: </strong>Significant improvements in pain intensity were observed in both groups and sustained over 6 months. Responder rates at 6 months were comparable between the GIB-only (41.7%) and GIB with CESI (45.0%) groups (<i>p</i> > 0.05). Multivariable analysis revealed that greater early pain relief (baseline to 1 h) significantly predicted 6-month favorable outcomes (OR: 2.08; 95% CI: 1.26-3.42; <i>p</i> = 0.004), whereas male sex was associated with significantly reduced odds of response (OR: 0.11; 95% CI: 0.02-0.72; <i>p</i> = 0.022).</p><p><strong>Conclusions: </strong>In this single-center retrospective cohort, GIB was associated with sustained pain relief in a substantial proportion of patients with chronic coccydynia, while the addition of CESI did not confer a clear incremental benefit. Importantly, immediate postprocedural pain relief served as a robust predictor of long-term success, whereas male sex was identified as a negative prognostic factor. Prospective, adequately powered randomized trials are needed to confirm these exploratory findings and to refine patient selection for GIB-based interventions. <b>Trial Registration:</b> ClinicalTrials.gov Identifier: NCT07200765.</p>","PeriodicalId":19913,"journal":{"name":"Pain Research & Management","volume":"2026 ","pages":"8614330"},"PeriodicalIF":3.0,"publicationDate":"2026-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12943467/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147326973","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-26eCollection Date: 2026-01-01DOI: 10.1155/prm/8255039
Zihan Xu, Nan An, Shuang Xu, Ruyun Wang, Yue Li
Objectives: We aimed to investigate changes in pain perception, acute exercise-induced hypoalgesia (EIH), and endogenous pain modulation responses following 4-week treadmill running exercises of different intensities in healthy individuals.
Methods: Fifty-six healthy individuals were included in this study. All participants were randomly assigned to a control group and three experimental groups (treadmill running at high intensity [TRH], treadmill running at moderate intensity [TRM], and treadmill running at low intensity [TRL]). All participants performed 12 treadmill running sessions within 4 weeks at different intensities based on their target heart rate (THR). A running assessment was administered 1 week before running sessions. The magnitudes of EIH, conditioned pain modulation (CPM), and temporal summation (TS) responses following regular treadmill running were assessed. Pressure pain thresholds (PPTs) or mechanical pain thresholds (MPTs) were also determined following regular treadmill running.
Results: All groups exhibited an EIH effect (p < 0.001, F = 9.424) with an increase in PPT and MPT during the running sessions (p = 0.004 and F = 2.084), and the TRM and TRL groups were significantly higher than the TRH group (p < 0.001). The CPM of the TRM and TRL groups significantly increased (p < 0.001), and the TS of the TRM significantly decreased (p < 0.001). Correlation analysis showed that the acute EIH-A (r = 0.724, p < 0.001), EIH-L (r = 0.726, p < 0.001), and EIH-M (r = 0.347, p = 0.009) were positively correlated with the CPM, while EIH-A (r = -0.529, p < 0.001) and EIH-L (r = -0.544, p < 0.001) were negatively correlated with the TS.
Conclusion: A 4-week low-to-moderate intensity treadmill running improved acute EIH response by enhancing endogenous pain modulation in healthy individuals. Future studies should consider sex, behavior, and physiological factors to provide a comprehensive understanding of the changes in EIH following regular exercises.
目的:我们旨在研究健康个体在4周不同强度的跑步机运动后疼痛感知、急性运动诱导痛觉减退(EIH)和内源性疼痛调节反应的变化。方法:56名健康个体参加本研究。所有参与者随机分为对照组和3个实验组(高强度跑步机[TRH]、中等强度跑步机[TRM]和低强度跑步机[TRL])。所有参与者在4周内根据他们的目标心率(THR)进行了12次不同强度的跑步机跑步。在跑步前一周进行跑步评估。评估常规跑步后EIH、条件性疼痛调节(CPM)和时间累积(TS)反应的程度。压力疼痛阈值(PPTs)或机械疼痛阈值(MPTs)也在常规跑步机跑步后测定。结果:各组均表现出EIH效应(p < 0.001, F = 9.424),运动过程中PPT和MPT升高(p = 0.004, F = 2.084),且TRM和TRL组显著高于TRH组(p < 0.001)。TRM组和TRL组的CPM显著升高(p < 0.001), TRM组的TS显著降低(p < 0.001)。相关分析显示,急性EIH-A (r = 0.724, p < 0.001)、EIH- l (r = 0.726, p < 0.001)和EIH- m (r = 0.347, p = 0.009)与CPM呈正相关,而EIH-A (r = -0.529, p < 0.001)和EIH- l (r = -0.544, p < 0.001)与pts呈负相关。结论:4周低至中等强度跑步可通过增强内源性疼痛调节改善健康个体急性EIH反应。未来的研究应考虑性别、行为和生理因素,以全面了解定期锻炼后EIH的变化。试验注册:ClinicalTrials.gov标识符:ChiCTR2300074367。
{"title":"Effects of 4-Week Treadmill Running at Different Intensities on Exercise-Induced Hypoalgesia and Endogenous Pain Modulation in Healthy Individuals.","authors":"Zihan Xu, Nan An, Shuang Xu, Ruyun Wang, Yue Li","doi":"10.1155/prm/8255039","DOIUrl":"10.1155/prm/8255039","url":null,"abstract":"<p><strong>Objectives: </strong>We aimed to investigate changes in pain perception, acute exercise-induced hypoalgesia (EIH), and endogenous pain modulation responses following 4-week treadmill running exercises of different intensities in healthy individuals.</p><p><strong>Methods: </strong>Fifty-six healthy individuals were included in this study. All participants were randomly assigned to a control group and three experimental groups (treadmill running at high intensity [TRH], treadmill running at moderate intensity [TRM], and treadmill running at low intensity [TRL]). All participants performed 12 treadmill running sessions within 4 weeks at different intensities based on their target heart rate (THR). A running assessment was administered 1 week before running sessions. The magnitudes of EIH, conditioned pain modulation (CPM), and temporal summation (TS) responses following regular treadmill running were assessed. Pressure pain thresholds (PPTs) or mechanical pain thresholds (MPTs) were also determined following regular treadmill running.</p><p><strong>Results: </strong>All groups exhibited an EIH effect (<i>p</i> < 0.001, <i>F</i> = 9.424) with an increase in PPT and MPT during the running sessions (<i>p</i> = 0.004 and <i>F</i> = 2.084), and the TRM and TRL groups were significantly higher than the TRH group (<i>p</i> < 0.001). The CPM of the TRM and TRL groups significantly increased (<i>p</i> < 0.001), and the TS of the TRM significantly decreased (<i>p</i> < 0.001). Correlation analysis showed that the acute EIH-A (<i>r</i> = 0.724, <i>p</i> < 0.001), EIH-L (<i>r</i> = 0.726, <i>p</i> < 0.001), and EIH-M (<i>r</i> = 0.347, <i>p</i> = 0.009) were positively correlated with the CPM, while EIH-A (<i>r</i> = -0.529, <i>p</i> < 0.001) and EIH-L (<i>r</i> = -0.544, <i>p</i> < 0.001) were negatively correlated with the TS.</p><p><strong>Conclusion: </strong>A 4-week low-to-moderate intensity treadmill running improved acute EIH response by enhancing endogenous pain modulation in healthy individuals. Future studies should consider sex, behavior, and physiological factors to provide a comprehensive understanding of the changes in EIH following regular exercises.</p><p><strong>Trial registration: </strong>ClinicalTrials.gov identifier: ChiCTR2300074367.</p>","PeriodicalId":19913,"journal":{"name":"Pain Research & Management","volume":"2026 ","pages":"8255039"},"PeriodicalIF":3.0,"publicationDate":"2026-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12936697/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147326962","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-26eCollection Date: 2026-01-01DOI: 10.1155/prm/7008601
Ray M Lunasin, Guy Terry, Sharon Wang-Price
Objectives: To explore existing evidence and identify whether dry needling (DN) intervention has effects on sleep disturbance in patients with musculoskeletal pain.
Methods: The Arksey and O'Malley framework guided the scoping review methodology. Seven databases were searched for clinical trials investigating DN in musculoskeletal pain disorders. Methodological quality was assessed using the Physiotherapy Evidence Database (PEDro) scale. Data extraction included study year, location, study design, musculoskeletal pain disorder, needling intervention type, and sleep outcome measure utilized.
Results: After duplicates were removed, 2292 articles were identified, and 33 studies were included in the review after independent screening. Two supplemental searches (May 2023 and January 2024) in addition to a hand search yielded an additional 146 articles. A total of 21 of those studies were also included, increasing the total to 54 studies. A total of 46 (84%) articles were RCTs and 8 (16%) were single-group, pretest-posttest clinical trials. A total of 9 studies were of optimal quality (PEDro score ≥ 8), and 11 were of moderate-to-high quality (PEDro score = 7).
Discussion: Due to significant variability in intervention, sleep outcome measurement, patient population, and study methodology quality, the evidence is mixed and inconclusive to support or refute the effects of DN on sleep deficits in individuals with musculoskeletal pain. However, future studies investigating the effects of needling interventions on musculoskeletal pain conditions should include valid sleep outcome measurements if considered.
{"title":"The Effect of Dry Needling on Sleep Quality in Individuals With Musculoskeletal Pain Disorders.","authors":"Ray M Lunasin, Guy Terry, Sharon Wang-Price","doi":"10.1155/prm/7008601","DOIUrl":"10.1155/prm/7008601","url":null,"abstract":"<p><strong>Objectives: </strong>To explore existing evidence and identify whether dry needling (DN) intervention has effects on sleep disturbance in patients with musculoskeletal pain.</p><p><strong>Methods: </strong>The Arksey and O'Malley framework guided the scoping review methodology. Seven databases were searched for clinical trials investigating DN in musculoskeletal pain disorders. Methodological quality was assessed using the Physiotherapy Evidence Database (PEDro) scale. Data extraction included study year, location, study design, musculoskeletal pain disorder, needling intervention type, and sleep outcome measure utilized.</p><p><strong>Results: </strong>After duplicates were removed, 2292 articles were identified, and 33 studies were included in the review after independent screening. Two supplemental searches (May 2023 and January 2024) in addition to a hand search yielded an additional 146 articles. A total of 21 of those studies were also included, increasing the total to 54 studies. A total of 46 (84%) articles were RCTs and 8 (16%) were single-group, pretest-posttest clinical trials. A total of 9 studies were of optimal quality (PEDro score ≥ 8), and 11 were of moderate-to-high quality (PEDro score = 7).</p><p><strong>Discussion: </strong>Due to significant variability in intervention, sleep outcome measurement, patient population, and study methodology quality, the evidence is mixed and inconclusive to support or refute the effects of DN on sleep deficits in individuals with musculoskeletal pain. However, future studies investigating the effects of needling interventions on musculoskeletal pain conditions should include valid sleep outcome measurements if considered.</p>","PeriodicalId":19913,"journal":{"name":"Pain Research & Management","volume":"2026 ","pages":"7008601"},"PeriodicalIF":3.0,"publicationDate":"2026-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12936855/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147326956","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-25eCollection Date: 2026-01-01DOI: 10.1155/prm/3402006
Sam C C Chan, Tom C W Tsoi
Background: Studies revealed that contact-heat stimulations mediate pain perception due to temporal summation of second pain (TSSP). How heat intensity affects the reliability of the pain rating of individuals with different heat tolerance is not well examined. This study investigated (1) the influence of the preceding contact-heat stimuli with different levels of intensity on the reliability of subjective pain rating and (2) the differences in reliability of subjective pain rating of participants with high and low sensory sensitivity or heat tolerance.
Method: Participants with intact sensory function were divided into (1) high (n = 17) and low (n = 13) sensitivity groups based on the cutoff temperature of 42°C or (2) high (n = 18) and low (n = 12) pain-tolerance groups based on the cutoff temperature of 47°C equivalent to numerical rating scale (NRS) of 7. In each trial, participants were given a pair of 2-s contact-heat stimuli (an interstimulus interval of 2.5 s) at the left thenar eminence and were asked to report an NRS rating. Four blocks of intensity combinations were given: Low-Low, High-High, Low-High, and High-Low conditions, with 72 trials in each block.
Results: Findings revealed that high heat-tolerance group results had lower intraclass correlation coefficients (ICCs) when contact-heat stimuli were preceded by another with higher intensity (ICC = 0.551-0.747) compared to those preceded by lower intensity (ICC = 0.724-0.818). In contrast, the ICCs of the low heat-tolerance group were found to be relatively higher regardless of heat intensity (ICC = 0.595-0.806).
Conclusions: The TSSP effect reflected by lower pain rating reliability appears to be induced in the high heat-tolerance group when a contact-heat stimulation is preceded by another stimulation with higher intensity but with the same duration. This is possibly due to the longer offset time of contact-heat stimulations with higher intensity, and also the top-down modulatory effects in this high heat-tolerance group. Further electrophysiological studies would be needed to investigate the underlying neural processes of TSSP in individuals with different heat tolerance.
{"title":"Effects of Contact-Heat Stimulation Intensity on the Reliability of Subjective Pain Rating of Individuals With Different Heat Tolerance.","authors":"Sam C C Chan, Tom C W Tsoi","doi":"10.1155/prm/3402006","DOIUrl":"10.1155/prm/3402006","url":null,"abstract":"<p><strong>Background: </strong>Studies revealed that contact-heat stimulations mediate pain perception due to temporal summation of second pain (TSSP). How heat intensity affects the reliability of the pain rating of individuals with different heat tolerance is not well examined. This study investigated (1) the influence of the preceding contact-heat stimuli with different levels of intensity on the reliability of subjective pain rating and (2) the differences in reliability of subjective pain rating of participants with high and low sensory sensitivity or heat tolerance.</p><p><strong>Method: </strong>Participants with intact sensory function were divided into (1) high (<i>n</i> = 17) and low (<i>n</i> = 13) sensitivity groups based on the cutoff temperature of 42°C or (2) high (<i>n</i> = 18) and low (<i>n</i> = 12) pain-tolerance groups based on the cutoff temperature of 47°C equivalent to numerical rating scale (NRS) of 7. In each trial, participants were given a pair of 2-s contact-heat stimuli (an interstimulus interval of 2.5 s) at the left thenar eminence and were asked to report an NRS rating. Four blocks of intensity combinations were given: Low-Low, High-High, Low-High, and High-Low conditions, with 72 trials in each block.</p><p><strong>Results: </strong>Findings revealed that high heat-tolerance group results had lower intraclass correlation coefficients (ICCs) when contact-heat stimuli were preceded by another with higher intensity (ICC = 0.551-0.747) compared to those preceded by lower intensity (ICC = 0.724-0.818). In contrast, the ICCs of the low heat-tolerance group were found to be relatively higher regardless of heat intensity (ICC = 0.595-0.806).</p><p><strong>Conclusions: </strong>The TSSP effect reflected by lower pain rating reliability appears to be induced in the high heat-tolerance group when a contact-heat stimulation is preceded by another stimulation with higher intensity but with the same duration. This is possibly due to the longer offset time of contact-heat stimulations with higher intensity, and also the top-down modulatory effects in this high heat-tolerance group. Further electrophysiological studies would be needed to investigate the underlying neural processes of TSSP in individuals with different heat tolerance.</p>","PeriodicalId":19913,"journal":{"name":"Pain Research & Management","volume":"2026 ","pages":"3402006"},"PeriodicalIF":3.0,"publicationDate":"2026-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12933179/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147309007","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Joint pain is a major cause of chronic disability worldwide, with complex mechanisms and limited treatment options. Inflammatory cytokines have been implicated in the pathogenesis of joint pain; however, their causal roles remain unclear. This study employed Mendelian randomization (MR) to explore the causal relationships between 41 inflammatory cytokines and the risk of joint pain.
Methods: We integrated genome-wide association study (GWAS) summary statistics from European-ancestry populations, including data on joint pain (1451 cases and 461,559 controls) and inflammatory cytokine levels (8293 Finnish participants). Genetic variants meeting instrumental variable assumptions (p < 1 × 10-5) were selected. Causal estimates were derived using inverse-variance weighted (IVW), weighted median, and MR-Egger regression. Sensitivity analyses incorporated Cochran's Q test, MR-Egger intercept analysis, and leave-one-out validation to evaluate heterogeneity and potential pleiotropy.
Results: Cutaneous T-cell attracting chemokine (CTACK)/CCL27 (OR: 0.998 and 95% CI: 0.996-0.999) and interleukin-2 receptor α subunit (IL-2RA) (OR: 0.997 and 95% CI: 0.995-0.999) were inversely associated with the risk of joint pain, while interleukin-18 (IL-18) (OR: 1.0007 and 95% CI: 1.0001-1.0012) demonstrated a positive causal relationship. Sensitivity analyses supported the robustness of the main findings (Cochran's Q p = 0.413), though evidence of horizontal pleiotropy was detected (MR-Egger intercept p < 0.05).
Conclusion: This study identifies IL-18, CTACK, and IL-2RA as potential causal mediators of joint pain, providing genetic evidence that informs future precision approaches to analgesia. Future research should validate these findings across diverse populations and elucidate the molecular mechanisms underlying them to advance targeted therapies.
{"title":"Exploring the Causal Relationship Between Inflammatory Cytokines and Joint Pain: A Mendelian Randomization Study.","authors":"Zehui Yan, Yujia Xi, Changjiang Mu, Jingkai Di, Zijian Guo, Shuai Chen, Chuan Xiang","doi":"10.1155/prm/1958574","DOIUrl":"https://doi.org/10.1155/prm/1958574","url":null,"abstract":"<p><strong>Background: </strong>Joint pain is a major cause of chronic disability worldwide, with complex mechanisms and limited treatment options. Inflammatory cytokines have been implicated in the pathogenesis of joint pain; however, their causal roles remain unclear. This study employed Mendelian randomization (MR) to explore the causal relationships between 41 inflammatory cytokines and the risk of joint pain.</p><p><strong>Methods: </strong>We integrated genome-wide association study (GWAS) summary statistics from European-ancestry populations, including data on joint pain (1451 cases and 461,559 controls) and inflammatory cytokine levels (8293 Finnish participants). Genetic variants meeting instrumental variable assumptions (<i>p</i> < 1 × 10<sup>-5</sup>) were selected. Causal estimates were derived using inverse-variance weighted (IVW), weighted median, and MR-Egger regression. Sensitivity analyses incorporated Cochran's Q test, MR-Egger intercept analysis, and leave-one-out validation to evaluate heterogeneity and potential pleiotropy.</p><p><strong>Results: </strong>Cutaneous T-cell attracting chemokine (CTACK)/CCL27 (OR: 0.998 and 95% CI: 0.996-0.999) and interleukin-2 receptor <i>α</i> subunit (IL-2RA) (OR: 0.997 and 95% CI: 0.995-0.999) were inversely associated with the risk of joint pain, while interleukin-18 (IL-18) (OR: 1.0007 and 95% CI: 1.0001-1.0012) demonstrated a positive causal relationship. Sensitivity analyses supported the robustness of the main findings (Cochran's Q <i>p</i> = 0.413), though evidence of horizontal pleiotropy was detected (MR-Egger intercept <i>p</i> < 0.05).</p><p><strong>Conclusion: </strong>This study identifies IL-18, CTACK, and IL-2RA as potential causal mediators of joint pain, providing genetic evidence that informs future precision approaches to analgesia. Future research should validate these findings across diverse populations and elucidate the molecular mechanisms underlying them to advance targeted therapies.</p>","PeriodicalId":19913,"journal":{"name":"Pain Research & Management","volume":"2026 ","pages":"1958574"},"PeriodicalIF":3.0,"publicationDate":"2026-02-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12927910/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147284784","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}